A global team has cracked a decades-old mystery, revealing the atomic structures of the molecules in our eyes that allow us ...
Researchers led by developmental biologist Kathy Niakan at the University of Cambridge have used base editing in human embryos to learn more about human embryonic development. By deactivating a gene ...
Our genetic heritage is not a blueprint or an algorithm, as many biologists have imagined, but something else entirely.
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Robert Bell, PhD, chief scientific officer of Ascidian Therapeutics, and a colleague at work in the company’s Boston laboratory. Ascidian is partnering with Eli Lilly to develop RNA exon editors ...
For an investment of up to $1.9 billion, Eli Lilly will be able to use Ascidian Therapeutics’ platform that removes mutated exons from mRNA molecules, avoiding the expression of disease-causing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results